A study, named the amylAGE study, has been carried out involving 100 individuals with suspected Alzheimer's Disease (AD) to investigate the impact of age (in years) on amyloid beta protein concentrations.
The study conductors now aim to:
- Gain a better understanding of what to expect across a wider range of ages.
- Explore models for describing the trend in the dataset.
- Carry out predictions for amyloid beta levels at ages 75 to 110 years old.
What recommendations can you provide based on your findings?